319 related articles for article (PubMed ID: 32803850)
1. Extremely high birth prevalence of sickle cell disease in rural Tanzania.
Eastburg L; Peckham A; Kawira E; Chirangi B; Adler D; Akungo BD; Smart LR; Ambrose EE
Pediatr Blood Cancer; 2020 Nov; 67(11):e28620. PubMed ID: 32803850
[TBL] [Abstract][Full Text] [Related]
2. Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test.
Steele C; Sinski A; Asibey J; Hardy-Dessources MD; Elana G; Brennan C; Odame I; Hoppe C; Geisberg M; Serrao E; Quinn CT
Am J Hematol; 2019 Jan; 94(1):39-45. PubMed ID: 30290004
[TBL] [Abstract][Full Text] [Related]
3. Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Low-Income Setting.
Alvarez OA; Hustace T; Voltaire M; Mantero A; Liberus U; Saint Fleur R
Pediatrics; 2019 Oct; 144(4):. PubMed ID: 31530717
[TBL] [Abstract][Full Text] [Related]
4. Determination of birth prevalence of sickle cell disease using point of care test HemotypeSC™ at Rundu Hospital, Namibia.
Mano RM; Kuona P; Misihairabgwi JM
BMC Pediatr; 2024 May; 24(1):323. PubMed ID: 38730340
[TBL] [Abstract][Full Text] [Related]
5. Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
Kunz JB; Awad S; Happich M; Muckenthaler L; Lindner M; Gramer G; Okun JG; Hoffmann GF; Bruckner T; Muckenthaler MU; Kulozik AE
Ann Hematol; 2016 Feb; 95(3):397-402. PubMed ID: 26658910
[TBL] [Abstract][Full Text] [Related]
6. Newborn screening for sickle cell disease: an innovative pilot program to improve child survival in Dar es Salaam, Tanzania.
Nkya S; Mtei L; Soka D; Mdai V; Mwakale PB; Mrosso P; Mchoropa I; Rwezaula S; Azayo M; Ulenga N; Ngido M; Cox SE; D'Mello BS; Masanja H; Kabadi GS; Mbuya F; Mmbando B; Daniel Y; Streetly A; Killewo J; Tluway F; Lyimo M; Makani J
Int Health; 2019 Nov; 11(6):589-595. PubMed ID: 31145786
[TBL] [Abstract][Full Text] [Related]
7. Potential of point of care tests for newborn screening for sickle cell disease: Evaluation of HemotypeSC™ and sickle SCAN® in Tanzania.
Christopher H; Josephat E; Kaywanga F; Saul S; Mshana I; Kunambi P; Nasser A; Chamba C; Makani J; Nkya S
Int J Lab Hematol; 2022 Oct; 44(5):959-965. PubMed ID: 35775883
[TBL] [Abstract][Full Text] [Related]
8. Newborn Screening and Clinical Profile of Children With Sickle Cell Disease in a Tribal Area of Gujarat.
Dave K; Desai S; Italia Y; Mukherjee MB; Mehta P; Desai G
Indian Pediatr; 2022 Mar; 59(3):230-233. PubMed ID: 35014619
[TBL] [Abstract][Full Text] [Related]
9. Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study.
Nnodu OE; Sopekan A; Nnebe-Agumadu U; Ohiaeri C; Adeniran A; Shedul G; Isa HA; Owolabi O; Chianumba RI; Tanko Y; Iyobosa JH; Adekile AD; Olopade OI; Piel FB
Lancet Haematol; 2020 Jul; 7(7):e534-e540. PubMed ID: 32589979
[TBL] [Abstract][Full Text] [Related]
10. Trends in sickle cell trait and disease screening in the Republic of Uganda, 2014-2019.
Hernandez AG; Kiyaga C; Howard TA; Ssewanyana I; Ndeezi G; Aceng JR; Ware RE
Trop Med Int Health; 2021 Jan; 26(1):23-32. PubMed ID: 33151598
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Sickle Cell Trait and Reliability of Self-Reported Status among Expectant Parents in Nigeria: Implications for Targeted Newborn Screening.
Burnham-Marusich AR; Ezeanolue CO; Obiefune MC; Yang W; Osuji A; Ogidi AG; Hunt AT; Patel D; Ezeanolue EE
Public Health Genomics; 2016; 19(5):298-306. PubMed ID: 27614873
[TBL] [Abstract][Full Text] [Related]
12. Community based screening for sickle haemoglobin among pregnant women in Benue State, Nigeria: I-Care-to-Know, a Healthy Beginning Initiative.
Ezenwosu OU; Itanyi IU; Nnodu OE; Ogidi AG; Mgbeahurike F; Ezeanolue EE
BMC Pregnancy Childbirth; 2021 Jul; 21(1):498. PubMed ID: 34238241
[TBL] [Abstract][Full Text] [Related]
13. Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action.
Colombatti R; Martella M; Cattaneo L; Viola G; Cappellari A; Bergamo C; Azzena S; Schiavon S; Baraldi E; Dalla Barba B; Trafojer U; Corti P; Uggeri M; Tagliabue PE; Zorloni C; Bracchi M; Biondi A; Basso G; Masera N; Sainati L
Pediatr Blood Cancer; 2019 May; 66(5):e27657. PubMed ID: 30724025
[TBL] [Abstract][Full Text] [Related]
14. Neonatal Screening for Sickle Cell Disease in Western Andalusia: Results and Lessons Learnt after 3 Years of Implementation.
Núñez-Jurado D; Payán-Pernía S; Álvarez-Ríos AI; Jiménez-Jambrina M; Concepcion Pérez-De-Soto I; José Palma-Vallellano A; Zapata-Bautista R; Carlos Hernández-Castellet J; Paz Garrastazul-Sánchez M; Arqueros-Martínez V; Urbano-Ramos MDM; Abdelkader-Maanan M; Raúl García-Lozano J; Delgado-Pecellín C
Am J Perinatol; 2024 May; 41(S 01):e893-e900. PubMed ID: 36580977
[TBL] [Abstract][Full Text] [Related]
15. Surveillance for sickle cell disease, United Republic of Tanzania.
Ambrose EE; Smart LR; Charles M; Hernandez AG; Latham T; Hokororo A; Beyanga M; Howard TA; Kamugisha E; McElhinney KE; Tebuka E; Ware RE
Bull World Health Organ; 2020 Dec; 98(12):859-868. PubMed ID: 33293746
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and factors associated with renal dysfunction among children with sickle cell disease attending the sickle cell disease clinic at a tertiary hospital in Northwestern Tanzania.
Kimaro FD; Jumanne S; Sindato EM; Kayange N; Chami N
PLoS One; 2019; 14(6):e0218024. PubMed ID: 31211789
[TBL] [Abstract][Full Text] [Related]
17. The Consortium on Newborn Screening in Africa for sickle cell disease: study rationale and methodology.
Green NS; Zapfel A; Nnodu OE; Franklin P; Tubman VN; Chirande L; Kiyaga C; Chunda-Liyoka C; Awuonda B; Ohene-Frempong K; Inusa BPD; Ware RE; Odame I; Ambrose EE; Dogara LG; Oron AP; Willett C; Thompson AA; Berliner N; Coetzer TL; Novelli EM
Blood Adv; 2022 Dec; 6(24):6187-6197. PubMed ID: 36264096
[TBL] [Abstract][Full Text] [Related]
18. High birth prevalence of sickle cell disease in Northwestern Tanzania.
Ambrose EE; Makani J; Chami N; Masoza T; Kabyemera R; Peck RN; Kamugisha E; Manjurano A; Kayange N; Smart LR
Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28766840
[TBL] [Abstract][Full Text] [Related]
19. Newborn blood spot screening for sickle cell disease by using tandem mass spectrometry: implementation of a protocol to identify only the disease states of sickle cell disease.
Moat SJ; Rees D; King L; Ifederu A; Harvey K; Hall K; Lloyd G; Morrell C; Hillier S
Clin Chem; 2014 Feb; 60(2):373-80. PubMed ID: 24158758
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 Infection and Outcomes in Newborn Screening Cohorts of Sickle Cell Trait and Sickle Cell Disease in Michigan and Georgia.
Paulukonis ST; Snyder A; Smeltzer MP; Sutaria AN; Hurden I; Latta K; Chennuri S; Vichinsky E; Reeves SL
J Pediatr Hematol Oncol; 2023 May; 45(4):174-180. PubMed ID: 37083273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
